GGrantIndex
← Leaderboards

Allan D Hess

Johns Hopkins University

$7,721,444
Attributed
$7,721,444
Total exposure
9
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $443.9K · FY201216
$500K$375K$250K$125K$0
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$7,721,444 · 9

By mechanism

P01$3,276,669 · 3
P30$2,503,974 · 3
R01$1,613,801 · 2
R21$327,000 · 1

Top collaborators

No co-investigators on record.

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trials

Research focus

Clinical TrialsLaboratoriesCellsTumorQuality ControlProceduresMonitorLaboratory ResearchResearch PersonnelServicesBaseFlow CytometryNeoplastic CellLaboratory RatCytokineMhc Class Ii AntigenAntigensCryopreservationComprehensive Cancer CenterBiopsyCostCytokine GeneEquipmentBehavior

Grant awards (34)

Immunology and Cell Processing$274,929
P01 · FY2016 · CA · contact PI
SPECIMEN ACCESSIONING$95,272
P30 · FY2016 · CA · contact PI
HUMAN IMMUNOLOGY$73,733
P30 · FY2016 · CA · contact PI
Immunology and Cell Processing$274,929
P01 · FY2015 · CA · contact PI
SPECIMEN ACCESSIONING$95,272
P30 · FY2015 · CA · contact PI
HUMAN IMMUNOLOGY$73,733
P30 · FY2015 · CA · contact PI
Immunology and Cell Processing$266,680
P01 · FY2014 · CA · contact PI
SPECIMEN ACCESSIONING$91,432
P30 · FY2014 · CA · contact PI
HUMAN IMMUNOLOGY$70,761
P30 · FY2014 · CA · contact PI
Immunology and Cell Processing$258,432
P01 · FY2013 · CA · contact PI
SPECIMEN ACCESSIONING$89,072
P30 · FY2013 · CA · contact PI
HUMAN IMMUNOLOGY$68,936
P30 · FY2013 · CA · contact PI
Immunology and Cell Processing$274,929
P01 · FY2012 · CA · contact PI
SPECIMEN ACCESSIONING$95,272
P30 · FY2012 · CA · contact PI
HUMAN IMMUNOLOGY$73,733
P30 · FY2012 · CA · contact PI
Immunoregulation in Cyclosporine-Induced Autoimmunity$327,000
R21 · FY2003 · AI
INVARIANT CHAIN BASED VACCINE STRATEGIES$326,990
R01 · FY2003 · CA
CELL MEDIATED IMMUNE MECHANISMS IN ACCELERATED GRAFT ARTERIOSCLEROSIS (AGA)$498,057
P01 · FY2002 · HL
INVARIANT CHAIN BASED VACCINE STRATEGIES$318,778
R01 · FY2002 · CA
Core--Cell Sorting and Imaging Facility$250,404
P30 · FY2002 · CA
Core--Cell Sorting and Imaging Facility$250,404
P30 · FY2002 · CA
AUTOLOGOUS GRAFT VS HOST DISEASE$225,914
P01 · FY2002 · CA
CELL MEDIATED IMMUNE MECHANISMS IN ACCELERATED GRAFT ARTERIOSCLEROSIS (AGA)$498,057
P01 · FY2001 · HL
INVARIANT CHAIN BASED VACCINE STRATEGIES$309,491
R01 · FY2001 · CA
Core--Cell Sorting and Imaging Facility$250,404
P30 · FY2001 · CA
Core--Cell Sorting and Imaging Facility$250,404
P30 · FY2001 · CA
AUTOLOGOUS GRAFT VS HOST DISEASE$225,914
P01 · FY2001 · CA
Core--Cell Sorting and Imaging Facility$189,195
P30 · FY2001 · CA
SYNGENEIC GRAFT-VS-HOST DISEASE$357,148
R01 · FY2000 · AI
INVARIANT CHAIN BASED VACCINE STRATEGIES$301,394
R01 · FY2000 · CA
CORE--FLOW CYTOMETRY FACILITY$296,752
P30 · FY2000 · CA
CELL MEDIATED IMMUNE MECHANISMS IN ACCELERATED GRAFT ARTERIOSCLEROSIS (AGA)$252,914
P01 · FY2000 · HL
AUTOLOGOUS GRAFT VS HOST DISEASE$225,914
P01 · FY2000 · CA
CORE--FLOW CYTOMETRY FACILITY$189,195
P30 · FY2000 · CA